The crucial role of the number of mammary tissue-specific stem cells

Breast Cancer Research

Volumn 7, Issue 1, 2005, Pages 13-17

  Trichopoulos, Dimitrios ^a,b   Lagiou, Pagona ^b   Adami, Hans Olov ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Birth weight; Breast cancer; Estrogens; Insulin like growth factor; Perinatal; Stem cells

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN; SOMATOMEDIN;

BIRTH WEIGHT; BREAST CANCER; BREAST CELL; CANCER RISK; CARCINOGENESIS; CELL COUNT; CELL SPECIFICITY; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; MAMMARY GLAND; ORGAN WEIGHT; PERINATAL PERIOD; POSTMENOPAUSE; PREDICTION; PREGNANCY; REVIEW; STEM CELL; BREAST; BREAST TUMOR; EPIDEMIOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; INCIDENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL EXPOSURE; RISK FACTOR; THEORETICAL MODEL;

BREAST; BREAST NEOPLASMS; EPIDEMIOLOGIC STUDIES; ESTROGENS; FEMALE; HUMANS; INCIDENCE; MODELS, THEORETICAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SOMATOMEDINS; STEM CELLS;

EID: 13444266202     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr966     Document Type: Review

References (50)

1. Adami H-O, Signorello LB, Trichopoulos D: Towards an understanding of breast cancer etiology. Semin Cancer Biol 1998, 8: 255-262.
2. Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol 2001, 2:133-140.
3. Hankinson S, Hunter D: Breast cancer. In Textbook of Cancer Epidemiology. Edited by Adami HO, Hunter D, Trichopoulos D. New York: Oxford University Press; 2002:301-339.
4. Richie RC, Swanson JO: Breast cancer: a review of the literature. J Insur Med 2003, 35:85-101.
5. Valaoras V, MacMahon B, Trichopoulos D, Polychronopoulou A: Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965-1967. Int J Cancer 1969, 4:350-363.
6. Tretli S: Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer 1989, 44:23-30.
7. Ursin G, Longnecker MP, Haile RW, Greenland S: A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995, 6:137-141.
8. Hunter DJ, Willett WC: Diet, body size, and breast cancer. Epidemiol Rev 1993, 15:110-132.
9. Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, Trichopoulos D, Adami HO: Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 1998, 76:29-34.
10. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R: Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995, 87:1622-1629.
11. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998, 7:1133-1144.
12. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet 1996, 347:1713-1727.
13. Magnusson C, Baron JA, Correia N, Bergstrom R, Adami HO, Persson I: Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 1999, 81:339-344.
14. Beral V and Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427.
15. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, et al.: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003, 289:3243-3253.
16. Ford D, Easton DF, Peto J: Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Gen 1995, 57:1457-1462.
17. Adami H-O, Adams G, Boyle P, Ewertz M, Lee N, Lund E, Miller A, Olsson H, Steel M, Trichopoulos D, Tulinius H: Breast cancer etiology. Int J Cancer 1990, Suppl:22-39.
18. Weber BL, Nathanson KL: Low penetrance genes associated with increased risk for breast cancer. Eur J Cancer 2000, 36: 1193-1199.
19. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003, 9:5699-5704.
20. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004, 89:1102-1107.
21. Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in post-menopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002, 94:606-616.
22. Onland-Moret NC, Kaaks R, van Noord PA, Rinaldi S, Key T, Grobbee DE, Peeters PH: Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer. Br J Cancer 2003, 88: 394-1399.
23. MacMahon B, Cole P, Brown J, Paffenbarger R, Trichopoulos D, Yen S: Urine estrogens, frequency of ovulation and breast cancer risk: case-control study in premenopausal women. J Natl Cancer Inst 1982, 70:247-250.
24. Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev 1993, 15:48-65.
25. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M: Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and metaregression analysis. Lancet 2004, 363:1346-1353.
26. Trichopoulos D: Hypothesis: does breast cancer originate in utero? Lancet 1990, 335:939-940.
27. Ekbom A, Trichopoulos D, Adami H-O, Hsieh C-C, Lan S-J. Evidence of prenatal influences on breast cancer risk. Lancet 1992, 340:1015-1018.
28. Trichopoulos D, Lipman R: Mammary gland mass and breast cancer risk. Epidemiology 1992, 3:523-526.
29. Adami H-O, Persson I, Ekbom A, Wolk A, Pontén J, Trichopoulos D: The aetiology and pathogenesis of human breast cancer. Mutat Res 1995, 333:29-35.
30. Trichopoulos D, Lipworth L: Editorial: is cancer causation simpler than we thought, but more intractable? Epidemiology 1995, 6:347-349.
31. Lagiou P, Hsieh CC, Trichopoulos D, Xu B, Wuu J, Mucci L, Tamimi R, Adami HO, Cnattingius S: Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol 2003, 32:193-198.
32. Trichopoulos D: Intrauterine environment, mammary gland mass and breast cancer risk. Breast Cancer Res 2003, 5: 2-44.
33. Berkel H, Birdsell DC, Jenkins H: Breast augmentation: a risk factor for breast cancer? N Engl J Med 1992, 326: 649-1653.
34. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN: Breast cancer following augmentation mammoplasty (United States . Cancer Causes Control 2000, 11:819-27.
35. Potischman N, Troisi R: In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control 1999, 10:561-73.
36. Vatten LJ, Maehle BO, Lund Nilsen TI, Tretli S, Hsieh C-C, Trichopoulos D, Stuver SO: Birth weight as a predictor of breast cancer: a case-control study in Norway. Br J Cancer 2002, 86: 89-91.
37. Ahlgren M, Sorensen T, Wohlfahrt J, Haflidadottir A, Holst C, Melbye M: Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 2003, 107:997-1000.
38. Michels KB, Ekbom A: Caloric restriction and incidence of breast cancer. JAMA 2004, 291:1226-1230.
39. Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ: Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 1998, 90:37-42.
40. Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D: Low estrogen receptor a expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 1999, 354:1787-1788.
41. Russo J, Romero AI, Russo IH: Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomark Prev 1994, 3:219-224.
42. Lipworth L, Hsieh C-C, Wide L, Ekbom A, Yu S-Z, Yu G-P, Xu B, Hellerstein S, Carlstrom K, Trichopoulos D, et al.: Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999, 79:7-12.
43. Ahlborg UG, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A, Baron J, Trichopoulos D, Adami H-O: Organochlorine compounds in relation to breast cancer, endometrial cancer and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 1995, 25:463-531.
44. Moolgavkar SH, Day NE, Stevens RG: Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J Natl Cancer Inst 1980, 65:559-569.
45. Baik I, Becker PS, DeVito WJ, Lagiou P, Ballen K, Quesenberry PJ, Hsieh CC: Stem cells and prenatal origin of breast cancer. Cancer Causes Control 2004, 15:517-530.
46. Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, et al.: Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control 2002, 13:753-758.
47. Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D, Adami HO: Perinatal characteristics and adult mammographic patterns. Int J Cancer 1995, 61:177-180.
48. Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, Kalmanti M, Koliouskas D, Kosmidis H, Panagiotou JP, Piperopoulou F, et al.: The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 1997, 76:1241-1247.
49. Andersson SW, Bengtsson C, Hallberg L, Lapidus L, Niklasson A, Wallgren A, Hulthen L: Cancer risk in Swedish women: the relation to size at birth. Br J Cancer 2001, 84:1193-1198.
50. Russo J, Russo IH: Development of the human mammary gland. In The Mammary Gland. Edited by Neville MC, Daniel CW. New York: Plenum Press; 1987:67-93.